Franklin Covey Co. (FC) Sinks 10.84% After Earnings
· Stocks · QuoteReporter
Post Earning Analysis
Franklin Covey Co. (FC) Sinks 10.84% After Earnings
Franklin Covey Co. (FC) has demonstrated resilience and strategic growth in its fiscal Q3 2026, as highlighted in their recent earnings call. Despite facing market challenges, the company has managed to exceed expectations, which is a bullish signal for investors. The details from the earnings snapshot and financial results indicate that Franklin Covey is effectively navigating through economic pressures, which could translate into sustained growth and potentially higher stock valuations in the near term.
The company's focus on integrating human elements with technological advancements, as discussed in their latest commentary on AI, suggests a strategic alignment that could differentiate them from competitors. This approach not only enhances their service offerings but also positions them well within the industry to capitalize on both tech-driven efficiency and the irreplaceable human touch in business solutions.
Investors should closely watch Franklin Covey's next quarterly report, as it will provide critical insights into whether these strategies are translating into continued financial improvement and market share expansion. This upcoming report will be crucial in confirming the current bullish outlook and could further influence the stock's trajectory based on the company's performance consistency.
The current price of the stock is $22.28, experiencing a significant drop today of approximately 10.84%. The Relative Strength Index (RSI) at 42.04 suggests the stock is neither overbought nor oversold, leaning slightly towards the bearish territory. The Moving Average Convergence Divergence (MACD) at 0.31 indicates a weak bullish momentum, which might not be sufficient to reverse the current downward trend.
Comparing the current price to moving averages, the stock is trading below the 20-day and 50-day moving averages by 7.12% and 3.00% respectively, but remains 18.76% above the 200-day moving average. This positioning suggests a short-term bearish trend but maintains a longer-term bullish outlook.
The stock is currently 16.9% below its 52-week high of $26.81 and has risen 99.64% from its 52-week low of $11.16. This wide range indicates significant volatility but also a strong recovery from the lows of the year.
Overall, the price action and technical indicators imply that market sentiment is currently cautious, reflecting uncertainty about the stock's ability to sustain its longer-term uptrend amidst recent declines.
Earnings Trend Table
| Date | Estimate EPS | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-07-01 | This field is available for premium subscribers only. Please visit https://api-ninjas.com/pricing to upgrade. | 0.27 | |
| 2025-04-02 | -0.13 | -0.08 | 37.25 |
| 2025-01-08 | 0.15 | 0.09 | -38.98 |
| 2024-11-06 | 0.82 | 0.89 | 8.98 |
| 2024-06-26 | 0.39 | 0.43 | 10.26 |
| 2024-03-27 | 0.05 | 0.13 | 147.62 |
| 2024-01-04 | 0.19 | 0.36 | 92.0 |
| 2023-11-01 | 0.49 | 0.49 | 1.03 |
The earnings per share (EPS) trend for the company under review shows a fluctuating but generally positive trajectory over the recent quarters. Starting from Q4 2023, the EPS was reported at 0.49, consistent with estimates. A significant jump was observed in Q1 2024, where EPS rose to 0.36, far exceeding the estimate of 0.19, marking a 92.0% surprise. This upward trend continued into Q2 2024, with EPS reaching 0.13, again surpassing expectations significantly by 147.62%.
However, a peak was reached in Q3 2024 with an EPS of 0.89, outperforming the estimate of 0.82. Post this peak, there was a notable decline in Q4 2024, where EPS decreased to 0.43, although it still beat the estimate of 0.39. The downward trend continued into Q1 2025, with EPS further dropping to 0.09, underperforming against the estimate of 0.15. A slight recovery was seen in Q2 2025, with EPS improving to -0.08, better than the expected -0.13.
This trend of initial strong growth followed by a recent deceleration could be concerning for investors, suggesting potential challenges in maintaining the high growth rates previously seen. The recent recovery in Q2 2025, despite being negative, indicates some resilience. Looking forward, the trajectory suggests that the company might face challenges in beating the next quarter's consensus, especially if the underlying issues causing the recent deceleration are not addressed.
The four most recent rating changes for the stock in question show a mix of actions from various firms:
- On November 17, 2022, Northland Capital initiated coverage with an "Outperform" rating and a target price of $100.
- On January 9, 2018, Barrington Research upgraded the stock from "Market Perform" to "Outperform," setting a target price at $32.
- On December 28, 2016, Barrington Research downgraded the stock from "Outperform" to "Market Perform," without specifying a target price.
- On November 5, 2015, ROTH Capital reiterated a "Buy" rating, adjusting the target price from $23 to $20.
The analyst consensus appears to be somewhat bullish, particularly with the significant target price of $100 from Northland Capital, suggesting a strong upside potential. This outlier target is notably higher than others and might reflect an optimistic view of the company's future growth or market position. Given the range of target prices and the actions (upgrades and positive initiations), the Street seems to lean towards a positive outlook on the stock.
However, whether this bullish stance is credible depends on the company's fundamentals and market conditions, which aren't detailed here. If the fundamentals are strong, Northland Capital’s aggressive target might be justified. Investors should consider whether the current stock price reflects this consensus and if there's meaningful upside to the average target.
In conclusion, trusting the consensus might be advisable if recent company performance and market conditions support the analysts' optimism. Otherwise, a cautious approach would be prudent, especially considering the significant variance in target prices.
With a current price of $22.28 and a consensus target of $32 from the most recent analyst upgrade by Barrington Research, the stock presents a potential upside of approximately 43.6%. This significant gap suggests that the market may be undervaluing the stock's future growth prospects or operational improvements.
The earnings per share (EPS) and dividend trends are not detailed here, but the substantial potential upside indicated by the target price suggests that recent performance or future expectations might be stronger than the market consensus. This could mean that the market is underpricing the company's ability to exceed performance expectations or effectively manage costs and drive profitability.
A critical second-order effect that the market might be missing is the potential for strategic initiatives or market expansions that could significantly enhance earnings in the near term. If the company has been investing in technology, entering new markets, or optimizing its operations, these factors could be undervalued by the market.
The next quarterly earnings report will be a crucial catalyst. If the report shows improved profitability, revenue growth, or successful strategic initiatives, it would confirm the view that the stock is undervalued. Conversely, a failure to meet these benchmarks could suggest that the current market pricing is justified.
Disclaimer
The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.